NL
ENSarcoïdose algemeen
Neurosarcoïdose
Dunne vezel neuropathie
Sarcoïdose oorzaak
Sarcoïdose diagnostiek
Sarcoïdose therapie
Clinics in Chest Medicine 2008
Monograph 2005; 32: Sarcoidosis
Abstracts WASOGBAL 2011
Sarcoïdose algemeen
Drent M.
Sarcoïdose: een grillige aandoening.
Ned Tijdschr Dermatol Venereol 2012; 22: 514-521.
Drent M, Lower EE, De Vries J.
Sarcoidosis-associated fatigue.
Eur Respir J 2012; 40: 255–263.
Drent M.
Sarcoïdose: stand van zaken.
FarmacotherapieOnline. Februari 2012: 1-25.
Drent M.
Nederlands enige kenniscentrum voor sarcoïdose.
Praktijk 2009; 4: 12-13.
Van den Boom R, Veldhuis Kroeze EJB, Klein WR, et al.
Granulomatous pneumonia, lymphadenopathy, and hepatopathy in an adult horse with repeated injection of BCG.
J Vet Intern Med 2008;22:1056–60.
Drent M.
Sarcoïdose: een aandoening met een grillig karakter.
Modern Med 2008;10: 357-61.
Reijerkerk EPR, Veldhuis Kroeze EJB, Sloet van Oldruitenborgh-Oosterbaan MM.
Generalized sarcoidosis in two horses.
Tijdschr Diergeneesk 2008;133:654-61.
Schilstra A, Rottoli P, Jacobs JA, van Suylen RJ, Galluzzi P, Drent M.
Case studies to explore the pitfalls in the diagnosis of sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 135-40.
Drent M.
Sarcoidosis: benefits of a multidisciplinary approach.
Eur J Intern Med 2003; 14: 217–220.
Drent M.
Sarcoïdose en vermoeidheid.
Modern Med 2003;11:830-836.
James DG, Sharma OP.
From Hudchinson till now: a historical glimpse.
Curr Opin Pulm Med 2002;8: 416-423.
Statement on sarcoidosis.
Am J Respir Crit Care Med 1999; 160: 736-755
Wirnsberger RM, De Vries J, Wouters EFM, Drent M.
Clinical presentation of sarcoidosis in the Netherlands. An epidemiological study.
Neth J Med 1998;53;53-60.
Neurosarcoïdose
Hoyle JC, Jablonski C, Newton HB.
Neurosarcoidosis: clinical review of a disorder with challenging inpatient presentations and diagnostic considerations.
Neurohospitalist 2014;4(2):94-101.
Download PDF
Hoitsma E, Drent M, Sharma OP.
A pragmatic approach to diagnosing and treating neurosarcoidosis in the 21st century.
Cur Opinion Pulm Med 2010: 16: 472-479
Download PDF
Hoitsma E, Faber CG, Drent M, Sharma OP.
Neurosarcoidosis: A clinical dilemma.
Lancet Neurol 2004: 3: 397-407.
Download PDF
Dunne vezel neuropathie
Hoitsma E.
Dunne vezelneuropathie: Pijnlijke klachten.
ild care today 2011; 4 (2): 24-29.
Download PDF
Tavee J, Culver D.
Sarcoidosis and small-fiber neuropathy.
Curr Pain Headache Rep 2011;15(3):201-6.
Download PDF
Hoitsma E, De Vries J, Drent M.
The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis.
Repir Med 2011; 105: 95-100.
Download PDF
Hoitsma E, Faber CG, van Kroonenburgh MJPG, Gorgels APM, Halders SGEA, Heidendal GAK, Kessels AGH, Reulen JPH, Drent M.
Cardiac sympathetic dysfunction and small fiber neuropathy: a common problem in sarcoidosis?
Sarcoidosis Vasc Diffuse Lung Dis 2005; 22: 43-50.
Download PDF
Hoitsma E, Reulen JPH, de Baets M, Drent M, Spaans F, Faber CG.
Small fiber neuropathy: a common and important clinical disorder.
J Neurol Sciences 2004; 227: 119-30.
Download PDF
Verbraecken J, Hoitsma E, van der Grinten CPM, Cobben NAM, Wouters EFM, Drent M.
Restless legs en PLMD: missing link tussen sarcoïdose en vermoeidheid?
Neuron 2004; 9: 249-55.
Download PDF
Hoitsma E, Drent M, Verstraete E, Faber CG, Troost J, Spaans F, Reulen JPH.
Abnormal warm and cold sensation thresholds suggestive of small fiber neuropathy in sarcoidosis.
Clin Neurophysiol 2003; 14: 2326-33.
Download PDF
Hoitsma E, Marziniak M, Faber CG, Reulen J, Sommer C, De Baets M, Drent M.
Small fiber neuropathy in sarcoidosis.
Lancet 2002; 359: 2085-86.
Download PDF
Oorzaak sarcoïdose
Drent M, Wijnen PA, Boots AW, Bast A.
Cat litter is a possible trigger for sarcoidosis.
Eur Respir J 2012; 39: 221-22.
Drent M, Bomans PHH, van Suylen RJ, et al.
Association of man-made mineral fibre exposure and sarcoidlike granulomas.
Respir Med 2000; 94: 815-20.
Thomeer M, Van Bleyenbergh P, Nemery B, Demedts M.
A breathless accountant who blew up balloons.
Lancet 1999; 354: 124.
Brandt K.H.
Een patiënt met idiopathische hypothyreoïdie tevens lijdende aan sarcoïdose.
Ned Tijdsch Geneesk 1964; 108; 2456-61.
Sarcoïdose diagnostiek
Mostard RLM, van Kroonenburgh MJPG, Drent M.
The role of the PET-scan in the management of sarcoidosis.
Curr Opin Pulm Med 2013; 2013;19: 538-544.
Marcellis RGJ, Lenssen AF, de Vries GJ, Baughman RP, De Vries J, Drent M.
Is there an added value of cardiopulmonary exercise testing in sarcoidosis patients?
Lung 2013; 191: 43-52.
Mostard RLM, Vöö S, van Kroonenburgh MJPG, Wijnen PAHM, Nelemans PJ, Erckens RJ, Drent M.
Inflammation assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis patients.
Repir Med 2011; 105: 1917-24
Hoitsma E, De Vries J, Drent M.
The small fiber neuropathy screening list: construction and cross-validation in sarcoidosis.
Repir Med 2011; 105: 95-100.
Kleijn WPE de, De Vries J, Wijnen PAHM, Drent M.
Minimal (clinically) important differences for the Fatigue Assessment Scale in sarcoidosis.
Respir Med 2011; 105: 1388-95.
Baughman RP, Engel EJ, Meyers CA, Barrett AB, Lower EE.
Pulmonary hypertension in sarcoidosis.
Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 108-16.
Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PGH, Drent M.
Usefulness of inflammatory markers to depict respiratory functional impairment in sarcoidosis.
Clin Chem 2003; 49:1510–7.
Drent M, Jacobs J, de Vries J, Lamers R, Liem I, Wouters E.
Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis?
Eur Respir J 1999; 13: 1338-1344.
Liem H, Drent M, Antevska E, Lamers R, Heidendal G.
Intense muscle uptake of Gallium-67 in a patient with sarcoidosis
J NucI Med 1998; 39: I605-1607.
Drent M, Wagenaar S, Mulder P, et al.
Bronchoalveolar lavage fluid profiles in sarcoidosis, tuberculosis, and Non-Hodgkin’s and Hodgkin’s disease. An evaluation of differences.
Chest 1994; 105: 514-19.
Drent M, van Velzen-Blad H, Diamant M, et al.
Relationship between presentation of sarcoidosis and T lymphocyte profile. A study in bronchoalveolar lavage fluid.
Chest 1993; 104:795-800.
Altas of granulomatous diseases
Therapie sarcoïdose
Heij L, Niesters, Swartjes M, Hoitsma E, Drent M, Dunne A, Grutters J, Vogels O, Brines M, Cerami A, Dahan A.
Safety and efficacy of ARA290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double blind, pilot study.
Mol Medicine 2012; 18: 1430-6.
Erckens RJ , Mostard RLM, Wijnen PAHM, Schouten SJAG, Drent M.
Adalimumab therapy successful in sarcoidosis patients with chronic non-infectious uveitis.
Graefes Arch Clin Exp Ophtalmonol 2012; 250: 713-20.
Behandeling van sarcoïdose met TNF-alfa blokkerende middelen:
position paper NVALT. 2012
Baughman RP, Lower EE, Drent M.
Inhibitors of tumor necrosis factor (TNF) in sarcoidosis: Who, what, and how to use them.
Sarcoidosis Vasc Diffuse Lung Dis 2008; 25: 76-89.
Drent M.
Sarcoidosis: is there a role for anti-TNF-α?
Portuguese J Pneumonology 2007; 8:51-58.
Boots AW.
Sarcoïdose:een rol voor antioxidant therapie?
Pulmoresults today 2007;3: 1-5.
Drent M, Grutters JC, Jansen TLThA, van der Heijde D.
Sarcoïdose: ontwikkelingen in de medicamenteuze behandeling
Ned Tijdschr Allergie 2007; 7: 82-90.
Baughman RP, Drent M, Kavuru M, et al.
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
Am J Respir Crit Care Med 2006;174:795-802.
Hoitsma E, Faber C, van Santen-Hoeufft M, et al.
Improvement of small fiber neuropathy in a sarcoidosis after treatment with infliximab
Sarcoidosis Vasc Diffuse Lung Dis 2006; 23: 73-77.
Drent M.
Zeldzaam gewoon. Grensverleggende geneeskunde voor topreferente patiënten.
Nederlandse Federatie van Universitair Medische Centra. Nieuwegein. 2005 :68-74.
Fouchier S, Möller G, van Santen-Hoefft M, et al.
Succesvolle behandeling van therapie-resistente sarcoïdose met infliximab.
[Successful treatment with infliximab of a patient with refractory sarcoidosis.]
Ned Tijdschr Geneesk 2004:148; 2446-2450.
Paramothayan S, Jones PW.
Corticosteroid therapy in pulmonary sarcoidosis: A systematic review.
JAMA. 2002; 287:1301-07.
Clin Chest Med 2008; 29: Sarcoidosis.
Contents.
Clin Chest Med 2008; 29:vii-x
Baughman PP, Drent M. Preface.
Clin Chest Med 2008; 29: xiii-xiv.
Sharma Op. Sarcoidosis around the world.
Clin Chest Med 2008; 29: 357-63.
Chen ES, Moller DR. Etiology of sarcoidosis.
Clin Chest Med 2008; 29: 365-77.
Gerke AK, Hunninghake G. The Immunology of sarcoidosis.
Clin Chest Med 2008; 29: 379-90.
Müller-Quernheim J, Schürmann M, Hofmann S, et al. Genetics of sarcoidosis.
Clin Chest Med 2008; 29: 391-414.
Judson MA.The diagnosis of sarcoidosis.
Clin Chest Med 2008; 29: 415-27.
Akbar JJ, Meyer CA, Shipley RT, et al. Cardiopulmonary imaging in sarcoidosis.
Clin Chest Med 2008; 29: 429-43.
Bargagli E, Mazzi A, Rottoli P. Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas.
Clin Chest Med 2008; 29: 445-58.
Mihailovic-Vucinic V, Jovanovic D. Pulmonary Sarcoidosis.
Clin Chest Med 2008; 29: 459-73.
Lower EE, Weiss KL. Neurosarcoidosis.
Clin Chest Med 2008; 29: 475-92.
Ayyala US, Nair AP, Padilla ML. Cardiac sarcoidosis.
Clin Chest Med 2008; 29: 493-508.
Rose AS, Tielker MA, Knox KS. Hepatic, ocular, and cutaneous sarcoidosis.
Clin Chest Med 2008; 29: 509-24.
De Vries J, Drent M. Quality of life and health status in sarcoidosis: A review of the literature.
Clin Chest Med 2008; 29: 525-32.
Baughman RP, Costabel U, du Bois RM. Treatment of sarcoidosis.
Clin Chest Med 2008; 29: 533-48.
Diaz-Guzman E, Farver C, Parambil J, Culver DA. Pulmonary hypertension caused by sarcoidosis.
Clin Chest Med 2008; 29: 549-63.
Nagai S, Handa T, Ito Y, et al. Outcome of sarcoidosis.
Clin Chest Med 2008; 29: 565-74.
Monograph Sarcoidosis 32, September 2005
Published with permission of the ERS
The guest editors
Eur Respir Mon 2005; 32: vii.
Preface
Wouters EFM.
Eur Respir Mon 2005; 32: viii.
Introduction
Drent M, Costabel U.
Eur Respir Mon 2005; 32: ix.
Definition and history of sarcoidosis
Sharma OP.
Eur Respir Mon 2005; 32: 1–12.
Epidemiology of sarcoidosis
Thomeer M, Demedts M, Wuyts W.
Eur Respir Mon 2005; 32: 13–22.
Aetiologies of sarcoidosis
Newman LS.
Eur Respir Mon 2005; 32: 23–48.
Immunology and pathophysiology
Semenzato G, Bortoli M, Brunetta E, Agostini C.
Eur Respir Mon 2005; 32: 49–63.
Genetics
du Bois RM, Beirne PA, Anevlavis SE.
Eur Respir Mon 2005; 32: 64–81.
Pathology
Poletti V, Casoni G, Chilosi M.
Eur Respir Mon 2005; 32: 82–91.
Fatigue, quality of life and health status in sarcoidosis
De Vries J, Wirnsberger RM.
Eur Respir Mon 2005; 32: 92–104.
Pulmonary sarcoidosis
Lynch 3rd JP, White ES.
Eur Respir Mon 2005; 32: 105–129.
Cardiac involvement in sarcoidosis
Schulte W, Kirsten D, Drent M, Costabel U.
Eur Respir Mon 2005; 32: 130–149.
Skin manifestations in sarcoidosis
Eklund A, Rizzato G.
Eur Respir Mon 2005; 32: 150–163.
Neurosarcoidosis
Hoitsma E, Sharma OP.
Eur Respir Mon 2005; 32: 164–187.
Clinical aspects of ocular sarcoidosis
Ohara K, Judson MA, Baughman RP.
Eur Respir Mon 2005; 32: 188–209.
Sarcoidosis: joint, muscle and bone involvement
Jansen TLThA, Geusens PPMM.
Eur Respir Mon 2005; 32: 210–219.
Renal sarcoidosis and hypercalcaemia
Sharma OP.
Eur Respir Mon 2005; 32: 220–232.
Rare manifestations of sarcoidosis
Moller DR.
Eur Respir Mon 2005; 32: 233–250.
Sarcoidosis in children
Clement A, Epaud R, Fauroux B.
Eur Respir Mon 2005; 32: 251–258.
Diagnostic approach to sarcoidosis
Costabel U, Guzman J, Drent M.
Eur Respir Mon 2005; 32: 259–264.
Sarcoidosis: imaging features
Verschakelen JA.
Eur Respir Mon 2005; 32: 265–283.
Clinical usefulness of nuclear imaging techniques in sarcoidosis
Mañá J, van Kroonenburgh M.
Eur Respir Mon 2005; 32: 284–300.
Therapy for sarcoidosis
Baughman RP, Lower EE.
Eur Respir Mon 2005; 32: 301–315.
Rehabilitation programmes in sarcoidosis: a multidisciplinary approach
Spruit MA, Wouters EFM, Gosselink R.
Eur Respir Mon 2005; 32: 316–326.
Transplantation for sarcoidosis
Saleem I, Beirne SO, Egan JJ.
Eur Respir Mon 2005; 32: 327–334.
History of the WASOG and current activities
Rizzato G.
Eur Respir Mon 2005; 32: 335–336.
Sarcoidosis patient groups
Polite PY.
Eur Respir Mon 2005; 32: 337–339.